Overexpression of cyclooxygenase-2 in high-grade human transitional cell carcinoma of the upper urinary tract

BJU International

Volumn 91, Issue 1, 2003, Pages 109-114

  Oku, S ^c   Higashi, M ^c   Imazono, Y ^c   Sueyoshi, K ^a   Enokida, H ^c   Kubo, H ^c   Yonezawa, S ^c   Shirahama, T ^b  

^a Kagoshima City Hospital   (Japan)

^b Kagoshima Seikyo Hospital   (Japan)

^c NONE

Author keywords

Carcinogenesis; Cyclooxygenase 2; Renal pelvis; Transitional cell carcinoma; Ureter

Indexed keywords

CYCLOOXYGENASE 2; PROSTAGLANDIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER GRADING; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENZYME SYNTHESIS; EPITHELIUM TUMOR; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY PELVIS CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEPHROURETERECTOMY; PATHOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSITIONAL CELL CARCINOMA; URETER CARCINOMA; URINARY TRACT CARCINOMA; CANCER STAGING; ENZYME LOCALIZATION; EPITHELIUM; HUMAN TISSUE; KIDNEY PELVIS; URETER;

AGED; CARCINOMA, TRANSITIONAL CELL; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; KIDNEY NEOPLASMS; KIDNEY PELVIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RETROSPECTIVE STUDIES;

EID: 20244370474     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2003.03057.x     Document Type: Article

References (31)

1. Shiff SJ, Rigas B. Nonsteroidal anti-inflammatory drugs and colorectal cancer: Evolving concepts of their chemopreventive actions. Gastroenterology 1997;113: 1992-8
2. Subbaramaiah K, Zakim D, Weksler BB, Dannenberg AJ. Inhibition of cyclooxygenase: A novel approach to cancer prevention. Exp Bio Med 1997; 216: 201-10
3. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hot spots in p53. Science 1996;274: 430-2
4. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996;87: 803-9
5. Williams CS, Tsuji M, Reese J, Dey SK, Dubois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000;105: 1589-94
6. Sheng GG, Shao J, Sheng Het al. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-rastransformed rat intestinal epithelial cells. Gastroenterology 1997;113: 1883-91
7. Tsuji M, DuBois RN. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell 1995;83: 493-501
8. Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, Dubois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998;93: 705-16
9. Jones MK, Wang H, Peskar BMet al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing. Nature Med 1999;12: 1418-23
10. Tsuji M, Kawano S, Dubois RN. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 1997; 94 : 3336-40
11. Steinbach G, Lynch P, Philips RKB, Wallace MH, Hawk E, Gordon G. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000;342: 1946-52
12. Shirahama T. Cyclooxygenase-2 expression is up-regulated in transitional cell carcinoma and its preneoplastic lesions in the human urinary bladder. Clin Cancer Res 2000;6: 2424-30
13. Shirahama T, Sakakura C. Overexpression of cyclooxygenase-2 in squamous cell carcinoma of the urinary bladder. Clin Cancer Res 2001;7: 558-61
14. Palvio DH, Anderson JC, Falk E. Transitional cell tumors of the renal pelvis and ureter associated with capillarosclerosis indicating analgesic abuse. Cancer 1987;59: 972-6
15. Cosyns JP, Jadoul M, Squifflet JP, Wese FX, van Ypersele de Strihou C. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999;33: 1011-7
16. Christensen P, Rorbaek MM, Myhre JO. Latency in thorotrast-induced renal tumors. Scan J Urol Nephrol 1983;17: 127-30
17. The Japanese Urological Association and the Japanese Society of Pathology. General Rules for Clinical and Pathological Studies on Renal Pelvic and Ureteral Cancer, 1st Edn. Tokyo: Kanehara Press, 1990
18. Bradford A. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72: 248-54
19. Zar JH. Biostatistical Analysis, 3rd Edn. New Jersey: Prentice Hall, 1996
20. Kömhorff M, Guan Y, Shappell HW et al. Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas. Am J Pathol 2000; 157: 29-35
21. Edward MM, William C. Urothelial tumors of the renal pelvis and ureter. In Walsh PC, Retik AB, Vaughan ED, Wein AJ eds, Campbell's Urology, 7th Edn. Philadelphia: WB Saunders, 1998: 2383-94
22. Sano H, Kawahito Y, Wilder RLet al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55: 3785-9
23. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998;58: 4997-5001
24. Tucker ON, Dannenberg AJ, Yang EKet al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res 1999;59: 987-90
25. Giardiello FM, Hamilton SR, Krush AJ et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993;328: 1313-6
26. Mohammed SI, Knapp DW, Bostwick DG et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 1999;59: 5647-50
27. Bedwani R, Renganathan E, Kwhsky FE et al. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 1998;77: 1186-9
28. Shirahama T, Arima J, Akiba S, Sakakura C. Relationship between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder. Cancer 2001;92: 188-93
29. Sheehan KM, Sheehan K, O'Donoghue DP et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA 2000;282: 1254-7
30. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ. Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 1999;274: 10911-5
31. Anonymous. Database of p53 gene somatic mutations in human tumors and cell lines: Updated complication and future prospects. Nucl Acids Res 1997;25: 151-7